Scivision Biotech (TPE:1786) E10: NT$1.98 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1786 Scivision Biotech Inc TPE:1786
75 GF Score
Price NT$50.40
GF Value NT$101.14
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Scivision Biotech E10?

Scivision Biotech TPE:1786 +1.61% 75 E10 is NT$1.98 as of Jun. 2026. GuruFocus rates TPE:1786 with a GF Score™ of 75/100 and a GF Value™ of NT$101.14 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Scivision Biotech's adjusted earnings per share data for the three months ended in Jun. 2026 was NT$0.470. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$1.98 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Scivision Biotech's average E10 Growth Rate was 12.50% per year. During the past 3 years, the average E10 Growth Rate was 18.60% per year. During the past 5 years, the average E10 Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Scivision Biotech was 19.60% per year. The lowest was 12.70% per year. And the median was 18.60% per year.

As of today (2026-08-23), Scivision Biotech's current stock price is NT$50.40. Scivision Biotech's E10 for the quarter that ended in Jun. 2026 was NT$1.98. Scivision Biotech's Shiller PE Ratio of today is 25.45.

During the past 13 years, the highest Shiller PE Ratio of Scivision Biotech was 96.38. The lowest was 24.95. And the median was 54.25.


Scivision Biotech  (TPE:1786) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Scivision Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=50.40/1.98
=25.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Scivision Biotech was 96.38. The lowest was 24.95. And the median was 54.25.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Scivision Biotech E10 Related Terms


Scivision Biotech E10 Historical Data

* Premium members only.

The historical data trend for Scivision Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scivision Biotech E10 Chart

Scivision Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 1.11 1.29 1.71 1.85

Scivision Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 1.79 1.85 1.91 1.98

TPE:1786 vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Scivision Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scivision Biotech Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scivision Biotech's Shiller PE Ratio falls into.


TPE:1786
75GF Score
Scivision Biotech Inc TPE:1786
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scivision Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scivision Biotech's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.47/333.9520*333.9520
=0.470

Current CPI (Jun. 2026) = 333.9520.

Scivision Biotech Quarterly Data

per share eps CPI Adj_EPS
201609 -0.800 241.428 -1.107
201612 0.361 241.432 0.499
201703 -0.034 243.801 -0.047
201706 0.017 244.955 0.023
201709 0.017 246.819 0.023
201712 0.292 246.524 0.396
201803 0.606 249.554 0.811
201806 0.061 251.989 0.081
201809 0.272 252.439 0.360
201812 0.527 251.233 0.701
201903 0.439 254.202 0.577
201906 0.377 256.143 0.492
201909 0.387 256.759 0.503
201912 0.590 256.974 0.767
202003 0.535 258.115 0.692
202006 0.341 257.797 0.442
202009 0.461 260.280 0.591
202012 0.627 260.474 0.804
202103 0.370 264.877 0.466
202106 0.470 271.696 0.578
202109 0.300 274.310 0.365
202112 0.380 278.802 0.455
202203 0.410 287.504 0.476
202206 0.600 296.311 0.676
202209 0.690 296.808 0.776
202212 0.230 296.797 0.259
202303 0.470 301.836 0.520
202306 0.710 305.109 0.777
202309 0.760 307.789 0.825
202312 0.490 306.746 0.533
202403 0.710 312.332 0.759
202406 0.930 314.175 0.989
202409 0.800 315.301 0.847
202412 0.840 315.605 0.889
202503 0.770 319.799 0.804
202506 -0.220 322.561 -0.228
202509 0.790 324.800 0.812
202512 0.810 324.054 0.835
202603 0.290 330.213 0.293
202606 0.470 333.952 0.470

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$1.98 mean?
Scivision Biotech (TPE:1786) has a E10 of NT$1.98 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scivision Biotech and its competitors.
Is Scivision Biotech's E10 too high?
Scivision Biotech's current E10 is NT$1.98. Overall, Scivision Biotech has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scivision Biotech's E10 compare to ISRG and BDX?
Scivision Biotech's E10 of NT$1.98 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scivision Biotech and its competitors. Scivision Biotech's current E10 is NT$1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scivision Biotech stock overvalued right now?
Based on GuruFocus' analysis, Scivision Biotech (TPE:1786) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$101.14, compared to a current price of NT$50.40 — trading 50.2% below its estimated fair value. The current E10 is NT$1.98. Scivision Biotech's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Scivision Biotech (TPE:1786), the current E10 is NT$1.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scivision Biotech (TPE:1786) Overvalued in 2026?

Based on GuruFocus' analysis, Scivision Biotech stock appears to be undervalued. The current stock price of NT$50.40 is trading 50.2% below its estimated GF Value™ of NT$101.14. GuruFocus considers Scivision Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1786:

  • E10: NT$1.98
  • GF Value™: NT$101.14 vs. price of NT$50.40 (50.2% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the TPE:1786 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scivision Biotech Business Description

Address No. 1, South 1st Road, Qianzhen District, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.
75GF Score

Get the complete analysis for TPE:1786

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.40
Price
NT$101.14
GF Value